Balanced news tone
News Sentiment
HSCS sentiment intelligence
Heart Test Laboratories Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-1.8% over one week, +52.2% over four weeks, trend inactive, and below fair value.
Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Experience real-time quotes, in-depth charts, and analyst ratings
This article provides a comprehensive overview of HeartSciences Inc. (HSCS) stock information available on Webull, including real-time quotes, financial reports, analyst ratings, and corporate actions. It highlights recent news and analyst updates for HSCS, an AI-powered medical
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Mar 2026 20:40
- Source
- Webull
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
HeartSciences (Nasdaq:HSCS) - Stock Analysis
HeartSciences (Nasdaq:HSCS) is a medical technology company focused on AI-based ECG technology, with a market cap of US$8.9m. The company's revenue is forecast to grow significantly, but it has experienced substantial shareholder dilution and is not expected to break even until 2
- Tone
- Negative 40/100
- Event
- Earnings
- Published
- 02 Mar 2026 21:52
- Source
- Simply Wall St
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Mar 2026 08:00
- Source
- Market source
UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn’t the Only Problem.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jan 2026 08:00
- Source
- Barron's
Analysts Are Bullish on These Healthcare Stocks: Radiopharm Theranostics Limited Sponsored ADR (RADX), Novan (NOVN)
Healthcare analysts are bullish on Radiopharm Theranostics Limited Sponsored ADR (RADX) and Heart Test Laboratories, Inc. (HSCS), with both companies receiving "Buy" or "Strong Buy" ratings. Radiopharm Theranostics has an average price target indicating significant upside, while
- Tone
- Positive 72/100
- Event
- Analyst action
- Published
- 20 Dec 2025 05:09
- Source
- The Globe and Mail
Check out Heart Test Laboratories Equity Warrant Exp 15th June 2027's stock price (HSCSW) in real time
This article provides real-time stock information for Heart Test Laboratories Equity Warrant Exp 15th June 2027 (HSCSW), including its current price, volume, and 52-week range. It also lists key financial stats, recent news, and a brief company profile for HeartSciences Inc.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Dec 2025 10:08
- Source
- CNBC
Heart Test Laboratories Amends 2023 Equity Incentive Plan
Heart Test Laboratories, Inc. has amended its 2023 Equity Incentive Plan, increasing the maximum number of shares issuable to 1,250,000, subject to shareholder approval. The company also granted restricted shares and RSUs to executives and directors with specific vesting conditio
- Tone
- Negative 38/100
- Event
- Regulatory and legal
- Published
- 01 Dec 2025 04:22
- Source
- TipRanks
HeartSciences (NasdaqCM:HSCS) Stock Price
This article provides an overview of HeartSciences Inc. (HSCS), including its current stock performance, key financial details, company description, recent news, and competitors. It highlights the company's focus on AI-based technology for ECGs to detect cardiac dysfunction and i
- Tone
- Negative 32/100
- Event
- Market update
- Published
- 28 Jul 2025 20:53
- Source
- Simply Wall St
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
HeartSciences (Nasdaq: HSCS; HSCSW), an AI-powered medical technology company, reported its financial results for the third quarter of fiscal year 2025, which ended January 31, 2025, and provided a business update. Key highlights include significant progress towards FDA submissio
- Tone
- Positive 76/100
- Event
- Earnings
- Published
- 13 Mar 2025 16:15
- Source
- FinancialContent
Which DFW companies have performed best, worst on stock markets in 2024?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2024 07:00
- Source
- WFAA
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
HeartSciences announced that the European Patent Office has granted its patent application EP3834729, covering the use of AI-ECG to assess diastolic function of the heart. This technology is crucial for early detection of heart disease, as diastolic dysfunction is an early indica
- Tone
- Positive 85/100
- Event
- Market update
- Published
- 24 Apr 2024 04:28
- Source
- Diagnostic and Interventional Cardiology
HeartSciences Appoints Dr. Partho P. Sengupta, MD, MBBS, FACC, to its Scientific Advisory Board
HeartSciences (Nasdaq: HSCS; HSCSW) has appointed Dr. Partho P. Sengupta, a distinguished cardiologist and leader in AI-ECG research, to its Scientific Advisory Board. Dr. Sengupta, known for his extensive peer-reviewed publications and awards, will contribute his expertise to ad
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 26 Feb 2024 00:00
- Source
- citybiz
Pre-market Movers: HSCS, RNA, THAR, BGLC...
This RTTNews article from November 28, 2023, reports on biotech stocks making significant movements in pre-market trading. It highlights several companies experiencing gains, including Heart Test Laboratories (HSCS) and Avidity Biosciences (RNA), and others facing declines, such
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 28 Nov 2023 07:50
- Source
- RTTNews